The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Treatment of Acne Vulgaris
Abstract
CONTEXT: Management of acne vulgaris by nondermatologists is increasing. Current understanding of the different presentations of acne allows for individualized treatments and improved outcomes. OBJECTIVE: To review the best evidence available for individualized treatment of acne. DATA SOURCES: Search of MEDLINE, EMBASE, and the Cochrane database to search for all English-language articles on acne treatment from 1966 to 2004. STUDY SELECTION: Well-designed randomized controlled trials, meta-analyses, and other systematic reviews are the focus of this article. DATA EXTRACTION: Acne literature is characterized by a lack of standardization with respect to outcome measures and methods used to grade disease severity. DATA SYNTHESIS: Main outcome measures of 29 randomized double-blind trials that were evaluated included reductions in inflammatory, noninflammatory, and total acne lesion counts. Topical retinoids reduce the number of comedones and inflammatory lesions in the range of 40% to 70%. These agents are the mainstay of therapy in patients with comedones only. Other agents, including topical antimicrobials, oral antibiotics, hormonal therapy (in women), and isotretinoin all yield high response rates. Patients with mild to moderate severity inflammatory acne with papules and pustules should be treated with topical antibiotics combined with retinoids. Oral antibiotics are first-line therapy in patients with moderate to severe inflammatory acne while oral isotretinoin is indicated for severe nodular acne, treatment failures, scarring, frequent relapses, or in cases of severe psychological distress. Long-term topical or oral antibiotic therapy should be avoided when feasible to minimize occurrence of bacterial resistance. Isotretinoin is a powerful teratogen mandating strict precautions for use among women of childbearing age. CONCLUSIONS: Acne responses to treatment vary considerably. Frequently more than 1 treatment modality is used concomitantly. Best results are seen when treatments are individualized on the basis of clinical presentation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
PITT, B., ZANNAD, F., REMME, W. J., CODY, R., CASTAIGNE, A., PEREZ, A., PALENSKY, J., & WITTES, J. (2000) · Survey of Anesthesiology · doi:10.1097/00132586-200006000-00059 · Cited by 2,927
Gollnick, H., Cunliffe, W., Berson, D., Dreno, B., Finlay, A., Leyden, J. J., Shalita, A. R., & Thiboutot, D. (2003) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2003.618 · Cited by 817
Tetracyclines Inhibit Connective Tissue Breakdown by Multiple Non-Antimicrobial Mechanisms
Golub, L. M., Lee, H.-M., Ryan, M. E., Giannobile, W. V., Payne, J., & Sorsa, T. (1998) · Advances in Dental Research · doi:10.1177/08959374980120010501 · Cited by 687
Prolonged Remissions of Cystic and Conglobate Acne with 13-cis-Retinoic Acid
Peck, G. L., Olsen, T. G., Yoder, F. W., Strauss, J. S., Downing, D. T., Pandya, M., Butkus, D., & Arnaud-Battandier, J. (1979) · New England Journal of Medicine · doi:10.1056/nejm197902153000701 · Cited by 519
Acne vulgaris: a disease of Western civilization
Cordain, L., Lindeberg, S., Hurtado, M., Hill, K., Eaton, S. B., & Brand-Miller, J. (2002) · Archives of Dermatology · doi:10.1001/archderm.138.12.1584 · Cited by 500 · cited 1×
“In addition to these 4 basic mechanisms, genetic factors,(3) stress,(4) and possibly diet may influence the development and severity of acne.(5)”
BackgroundAntibiotic-resistant acne: lessons from Europe
Ross, J. I., Snelling, A. M., Carnegie, E., Coates, P., Cunliffe, W. J., Bettoli, V., Tosti, G., Katsambas, A., Galvan Perez Del Pulgar, J. I., Rollman, O., et al. (2003) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2003.05067.x · Cited by 360
Vowels, B. R., Yang, S., & Leyden, J. J. (1995) · Infection and Immunity · doi:10.1128/iai.63.8.3158-3165.1995 · Cited by 330
EADY, E. A., COVE, J. H., HOLLAND, K. T., & CUNLIFFE, W. J. (1989) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1989.tb01399.x · Cited by 279
THE EFFECT OF ANTIMICROBIAL AGENTS ON LEUKOCYTE CHEMOTAXIS
Esterly, N. B., Furey, N. L., & Flanagan, L. E. (1978) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12543487 · Cited by 254
Anxiety, depression, and nature of acne vulgaris in adolescents
Aktan, S., md, Özmen, E., md, S, B., cedil, anli, & md (2000) · International Journal of Dermatology · doi:10.1046/j.1365-4362.2000.00907.x · Cited by 243
Effects of subantimicrobial-dose doxycycline in the treatment of moderate acne
Skidmore, R., Kovach, R., Walker, C., Thomas, J., Bradshaw, M., Leyden, J., Powala, C., & Ashley, R. (2003) · Archives of Dermatology · doi:10.1001/archderm.139.4.459 · Cited by 238 · cited 2×
“01; Table 2).(42) Even low doses of doxycycline may be effective by inhibition of collagenases including matrix metalloproteinases.”
BackgroundIsotretinoin therapy for acne: results of a multicenter dose-response study
Strauss, J. S., Rapini, R. P., Shalita, A. R., Konecky, E., Pochi, P. E., Comite, H., & Exner, J. H. (1984) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(84)80100-0 · Cited by 223
Isotretinoin for acne vulgaris-10 years later; a safe and successful treatment
LAYTON, A. M., KNAGGS, H., TAYLOR, J., & CUNLIFFE, W. J. (1993) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1993.tb11849.x · Cited by 223
REDMOND, G., OLSON, W., LIPPMAN, J., KAFRISSEN, M., JONES, T., & JORIZZO, J. (1997) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(97)00059-8 · Cited by 221
Bataille, V., Snieder, H., MacGregor, A. J., Sasieni, P., & Spector, T. D. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.19621.x · Cited by 220
Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris
Lucky, A. W., Henderson, T. A., Olson, W. H., Robischb, D. M., Lebwohl, M., & Swinyer, L. J. (1997) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(97)70112-9 · Cited by 201
Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne
Brown, J., Farquhar, C., Lee, O., Toomath, R., & Jepson, R. G. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000194.pub2 · Cited by 196
Goulden, Mcgeown, & Cunliffe (1999) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1999.02979.x · Cited by 195
Acne therapy: A methodologic review
Lehmann, H. (2002) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(02)00052-x · Cited by 181
Cusan, L., Dupont, A., Gomez, J.-L., Tremblay, R. R., & Labrie, F. (1994) · Fertility and Sterility · doi:10.1016/s0015-0282(16)56518-2 · Cited by 178
Lookingbill, D. P., Chalker, D. K., Lindholm, J. S., Katz, H. I., Kempers, S. E., Huerter, C. J., Swinehart, J. M., Schelling, D. J., & Klauda, H. C. (1997) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(97)70177-4 · Cited by 173 · cited 1×
“Reasonable response expectations are in the range of 30% to 80%.(17-20,25,26) Figure.”
Backgroundvan Vloten, W. A., van Haselen, C. W., van Zuuren, E. J., Gerlinger, C., & Heithecker, R. (2002) · PubMed · Cited by 173
Minocycline-induced autoimmune syndromes: An overview
Elkayam, O., Yaron, M., & Caspi, D. (1999) · Seminars in Arthritis and Rheumatism · doi:10.1016/s0049-0172(99)80004-3 · Cited by 172
Oral spironolactone improves acne vulgaris and reduces sebum excretion
GOODFELLOW, A., ALAGHBAND-ZADEH, J., CARTER, G., CREAM, J. J., HOLLAND, S., SCULLY, J., & WISE, P. (1984) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1984.tb04045.x · Cited by 172
Androgen Metabolism in Sebaceous Glands From Subjects With and Without Acne
Thiboutot, D., Gilliland, K., Light, J., & Lookingbill, D. (1999) · Archives of Dermatology · doi:10.1001/archderm.135.9.1041 · Cited by 169
Stewart, F. H., Harper, C. C., Ellertson, C. E., Grimes, D. A., Sawaya, G. F., & Trussell, J. (2001) · JAMA · doi:10.1001/jama.285.17.2232 · Cited by 166
Systematic review of Propionibacterium acnes resistance to systemic antibiotics
Cooper, A. J. (1998) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1998.tb140250.x · Cited by 146
Oral spironolactone: an effective treatment for acne vulgaris in women
MUHLEMANN, M. F., CARTER, G. D., CREAM, J. J., & WISE, P. (1986) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1986.tb05722.x · Cited by 144
Cunliffe, Poncet, Loesche, C., & Verschoore (1998) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1998.1390s2048.x · Cited by 139
MALE HORMONE SUBSTANCE: A PRIME FACTOR IN ACNE1
Hamilton, J. B. (1941) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-1-7-570 · Cited by 134
Shaw, J. C. (2000) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2000.105557 · Cited by 134
Eady, E. A., Cove, J. H., & Layton, A. (2003) · American Journal of Clinical Dermatology · doi:10.2165/00128071-200304120-00002 · Cited by 126
A dose-response study of 13-cis-retinoic acid in acne vulgaris
Jones, D. H., KING, K., MIILER, A. J., & Cunliffe, W. J. (1983) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1983.tb03973.x · Cited by 125
Tissue production of androgens in women with acne
Lookingbill, D. P., Horton, R., Demers, L. M., Egan, N., Marks, J. G., & Santen, R. J. (1985) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(85)70067-9 · Cited by 123
Eady, E. A., Bojar, R. A., JONES, C. E., Cove, J. H., Holland, K. T., & Cunliffe, W. J. (1996) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1996.d01-733.x · Cited by 121
Dréno, B., Moyse, D., Alirezaï, M., Amblard, P., Auffret, N., Beylot, C., Bodokh, I., Chivot, M., Daniel, F., Humbert, P. G., et al. (2001) · Dermatology · doi:10.1159/000051728 · Cited by 119
Minocycline and Lupuslike Syndrome in Acne Patients
Sturkenboom, M., Meier, C. R., Jick, H., & Stricker, B. H. C. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.5.493 · Cited by 116
Cunliffe, W. J., Holland, K. T., Bojar, R. A., & Levy, S. F. (2002) · Clinical Therapeutics · doi:10.1016/s0149-2918(02)80023-6 · Cited by 113
Isotretinoin Use and Subsequent Depression and Suicide
Hull, P. R., & D'Arcy, C. (2003) · American Journal of Clinical Dermatology · doi:10.2165/00128071-200304070-00005 · Cited by 111
Mortality in relation to oral contraceptive use and cigarette smoking
Vessey, M. P., Painter, R., & Yeates, D. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13907-4 · Cited by 109
Update and Future of Hormonal Therapy in Acne
Thiboutot, D. M., & Chen, W. (2003) · Dermatology · doi:10.1159/000067823 · Cited by 106
Wolf, J. E., Kaplan, D., Kraus, S. J., Loven, K. H., Rist, T. E., Swinyer, L. J., Baker, M. D., Liu, Y. S., & Czernielewski, J. (2003) · Journal of the American Academy of Dermatology · doi:10.1067/s0190-9622(03)01152-6 · Cited by 105
The role of androgens in determining acne severity in adult women
Cibula, D., Hill, M., Vohradnikova, O., Kuzel, D., Fanta, M., & Zivny, J. (2000) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2000.03669.x · Cited by 101
Barth, J. H., MacDonald-Hull, S. P., Mark, J. J., Jones, R. G., & Cunliffe, W. J. (1993) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1993.tb03336.x · Cited by 97
Thiboutot, D., Archer, D. F., Lemay, A., Washenik, K., Roberts, J., & Harrison, D. D. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(01)01938-0 · Cited by 96
Falsetti, L., Gambera, A., & Tisi, G. (2001) · Human Reproduction · doi:10.1093/humrep/16.1.36 · Cited by 90
Worret, I., Arp, W., Zahradnik, H. P., Andreas, J., & Binder, N. (2001) · Dermatology · doi:10.1159/000051701 · Cited by 88
Long-term safety of spironolactone in acne: results of an 8-year followup study
Shaw, J. C., & White, L. E. (2002) · Journal of Cutaneous Medicine and Surgery · doi:10.1177/120347540200600604 · Cited by 86
den Ley, J. J., Hickman, J. G., Jarratt, M. T., Stewart, D. M., & Levy, S. F. (2001) · Journal of Cutaneous Medicine and Surgery · doi:10.1177/120347540100500109 · Cited by 82
The treatment of acne fulminans: a review of 25 cases
Seukeran, & Cunliffe (1999) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1999.02982.x · Cited by 82
Successful Treatment of Acne Vulgaris Using a New Method
Bershad, S. V., Singer, G., Parente, J. E., Tan, M., Sherer, D. W., Persaud, A. N., & Lebwohl, M. (2002) · Archives of Dermatology · doi:10.1001/archderm.138.4.481 · Cited by 82
Polycystic ovary syndrome: the new millenium
Legro, R. S. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(01)00640-2 · Cited by 82
Leyden, J., Shalita, A., Hordinsky, M., Swinyer, L., Stanczyk, F. Z., & Weber, M. E. (2002) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2002.122192 · Cited by 80
Graupe, K., Cunliffe, W. J., Gollnick, H. P. M., & Zaumseil, R. ‐. (1996) · PubMed · Cited by 80
Cunliffe, W. J., Meynadier, J., Alirezaï, M., George, S. A., Coutts, I., Roseeuw, D. I., Hachem, J. P., Briantais, P., Sidou, F., & Soto, P. (2003) · Journal of the American Academy of Dermatology · doi:10.1067/s0190-9622(03)01153-8 · Cited by 79
Shalita, A. R., Chalker, D. K., Griffith, R. F., Herbert, A. A., Hickman, J., Maloney, J. M., Miller, B. H., Tschen, E. H., Chandraratna, R. A. S., Gibson, J. R., et al. (1999) · PubMed · Cited by 77
Antibacterial Therapy for Acne
Tan, H. H. (2003) · American Journal of Clinical Dermatology · doi:10.2165/00128071-200304050-00002 · Cited by 77
Carmina, E., & Løbo, R. A. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01594.x · Cited by 77
Treatment of acne vulgaris with topically applied erythromycin and tretinoin
Mills, O., & Am, K. (1978) · Acta Dermato Venereologica · doi:10.2340/0001555558555557 · Cited by 72
Eady, E. A., JONES, C. E., Gardner, K., TAYLOR, J. P., Cove, J. H., & Cunliffe, W. J. (1993) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1993.tb00235.x · Cited by 69
WEBSTER, G. F., McGinley, K. J., & LEYDEN, J. J. (1981) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1981.tb15317.x · Cited by 66
Pochi, P. E., Strauss, J. S., & Mescon, H. (1962) · Journal of Investigative Dermatology · doi:10.1038/jid.1962.146 · Cited by 66
van Wayjen, R. G. A., & van den Ende, A. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1211357 · Cited by 65
Strauss, J. S., Leyden, J. J., Lucky, A. W., Lookingbill, D. P., Drake, L. A., Hanifin, J. M., Lowe, N. J., Jones, T. M., Stewart, D. M., Jarratt, M., et al. (2001) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2001.115966 · Cited by 64
Carlborg, L. (1986) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016348609157049 · Cited by 63
Ellis, C. N., Millikan, Smith, Chalker, Swinyer, Katz, Berger, Jr, M., Baker, Verschoore, et al. (1998) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1998.1390s2041.x · Cited by 63
Recurrence Rates After the First Course of Isotretinoin
White, G. M., Chen, W., Yao, J., & Wolde-Tsadik, G. (1998) · Archives of Dermatology · doi:10.1001/archderm.134.3.376 · Cited by 62
Clindamycin Phosphate Used in Combination with Tretinoin in the Treatment of Acne
Rietschel, R. L., & Duncan, S. H. (1983) · International Journal of Dermatology · doi:10.1111/j.1365-4362.1983.tb02113.x · Cited by 61
Strauss, J. S., Leyden, J. J., Lucky, A. W., Lookingbill, D. P., Drake, L. A., Hanifin, J. M., Lowe, N. J., Jones, T. M., Stewart, D. M., Jarratt, M., et al. (2001) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2001.115965 · Cited by 61
WEBSTER, G. F., Berson, D., Stein, L. F., Fivenson, D. P., Tanghetti, E. A., & LING, M. R. (2001) · PubMed · Cited by 59
(1989) · PubMed · Cited by 58
Habbema, L., KOOPMANS, B., Menke, H. E., Doornweerd, S., & Boulle, K. L. D. (1989) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1989.tb15518.x · Cited by 58
Leyden, J. J., Tanghetti, E. A., Miller, B. H., Ung, M., Berson, D. S., & Lee, J. (2002) · PubMed · Cited by 52
Topical erythromycin solution in acne
Dobson, R. L., & Belknap, B. S. (1980) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(80)80113-7 · Cited by 50
WEBSTER, G. F., Guenther, L., Poulin, Y. P., Solomon, B. A., Loven, K. H., & Lee, J. (2002) · PubMed · Cited by 48
Cunliffe, W. J., Danby, F. W., Dunlap, F. E., Gold, M. H., Gratton, D., & Greenspan, A. (2002) · PubMed · Cited by 45
Comparative efficacy of oral erythromycin versus oral tetracycline in the treatment of acne vulgaris
Gammon, W. R., Meyer, C., Lantis, S., Shenefelt, P. D., Reizner, G. T., & Cripps, D. J. (1986) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(86)70019-4 · Cited by 43
An evaluation of a 2% erythromycin ointment in the topical therapy of acne vulgaris
Lesher, J. L., Chalker, D. K., Smith, J. G., Guenther, L., Ellis, C. N., Voorhees, J. J., Shalita, A. R., & Klauda, H. C. (1985) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(85)70074-6 · Cited by 38
Topical Erythromycin vs Blank Vehicle in a Multiclinic Acne Study
Jones, E. L. (1981) · Archives of Dermatology · doi:10.1001/archderm.1981.01650090033020 · Cited by 36
Thiboutot, D. M., Gold, M. H., Jarratt, M., Kang, S., Kaplan, D. L., Millikan, L. E., Wolfe, J., Loesche, C., & Baker, M. (2001) · PubMed · Cited by 36
Ellis, C. N., Leyden, J., Katz, H. I., Goldfarb, M., Hickman, J., Jones, T. M., & Tschen, E. H. (2001) · PubMed · Cited by 35
Körting, H. C., & Braun‐Falco, O. (1989) · PubMed · Cited by 35
Vartiainen, M., de Gezelle, H., & Broekmeulen, C. J. H. (2001) · The European Journal of Contraception & Reproductive Health Care · doi:10.1080/ejc.6.1.46.53 · Cited by 34
Leyden, J., Lowe, N. J., Kakita, L. S., & Draelos, Z. D. (2001) · PubMed · Cited by 33
Generic isotretinoin: a new risk for unborn children
Koren, G., Avner, M., & Shear, N. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1040317 · Cited by 26
Topical clindamycin versus oral tetracycline and placebo in acne vulgaris.
Lr, B. (1984) · PubMed · Cited by 25
Lucky, A. W., Jorizzo, J. L., Rodriguez, D., Jones, T. M., Stewart, D. M., Tschen, E. H., Kanof, N. B., Miller, B. H., Wilson, D. C., & Loven, K. H. (2001) · PubMed · Cited by 23
Richter, J., Bousema, M. T., Boulle, K. D., Degreef, H., & Poli, F. (1998) · Journal of Dermatological Treatment · doi:10.3109/09546639809161377 · Cited by 15
Egan, N., Loesche, M. C., & Baker, M. (2001) · PubMed · Cited by 15
Cited by
Gierisch, J. M., Coeytaux, R. R., Urrutia, R. P., Havrilesky, L. J., Moorman, P. G., Lowery, W. J., Dinan, M., McBroom, A. J., Hasselblad, V., Sanders, G. D., et al. (2013) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0298 · Cited by 372
The epidemiology of acne vulgaris in late adolescence
Lynn, D., Umari, T., Dellavalle, R., & Dunnick, C. (2016) · Adolescent Health, Medicine and Therapeutics · doi:10.2147/ahmt.s55832 · Cited by 332
Wang, Y., Kuo, S., Shu, M., Yu, J., Huang, S., Dai, A., Two, A., Gallo, R. L., & Huang, C.-M. (2014) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-013-5394-8 · Cited by 300
Large‐scale worldwide observational study of adherence with acne therapy
Dréno, B., Thiboutot, D., Gollnick, H., Finlay, A. Y., Layton, A., Leyden, J. J., Leutenegger, E., Perez, M., & on behalf of the Global Alliance to Improve Outcomes in Acne (2010) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2010.04416.x · Cited by 195
Thiboutot, D. M., Weiss, J., Bucko, A., Eichenfield, L., Jones, T., Clark, S., Liu, Y., Graeber, M., & Kang, S. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2007.06.006 · Cited by 183
Metadata
- Authors
- Haider, A.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2004-08-11
- Volume
- 292
- Issue
- 6
- Pages
- 726
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W1976923360
- Cited by
- 273
- References
- 91
- FWCI
- 16.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.